Safety Profile of T-DM1 in HER2-Positive Advanced Breast Cancer: Final Results of the Global and Asia Cohorts of the KAMILLA Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer
ESMO Open 2022 Sep 06;7(5)100561, R Wuerstlein, P Ellis, F Montemurro, A Antón Torres, S Delaloge, Q Zhang, X Wang, S Wang, Z Shao, H Li, A Rachman, M Vongsaisuwon, H Liu, S Fear, C Peña-Murillo, C BarriosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.